NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 52 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,693,000 | -22.1% | 2,000,000 | -11.1% | 0.04% | -44.6% |
| Q4 2019 | $3,456,000 | +0.7% | 2,250,000 | -10.0% | 0.06% | -3.0% |
| Q3 2019 | $3,431,000 | -13.2% | 2,500,000 | -16.7% | 0.07% | -9.5% |
| Q2 2019 | $3,952,000 | -55.1% | 3,000,000 | -53.8% | 0.07% | -55.7% |
| Q1 2019 | $8,800,000 | -42.0% | 6,500,000 | -26.9% | 0.17% | -18.1% |
| Q3 2018 | $15,184,000 | -11.0% | 8,895,000 | -24.7% | 0.20% | -14.6% |
| Q2 2018 | $17,066,000 | – | 11,805,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |